Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.47 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL588375 | 0.91 | MDM4 (0.44) | MDM4TP53SLC17A5CASP3 | |
| SCHEMBL22738558 | 0.89 | MDM4 (0.45) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL30480131 | 0.89 | FDFT1 (0.49) | MDM4TP53CASP3MDM2 | |
| SCHEMBL23125120 | 0.88 | MDM4 (0.46) | MDM4TP53KMT2ACASP3MDM2 | |
| SCHEMBL10658405 | 0.88 | MDM4 (0.46) | MDM4TP53KMT2ACASP3MDM2 | |
| SCHEMBL30895511 | 0.88 | MDM4 (0.46) | MDM4TP53KMT2ACASP3MDM2 | |
| SCHEMBL23125122 | 0.88 | MDM4 (0.46) | MDM4TP53KMT2ACASP3MDM2 | |
| SCHEMBL16862728 | 0.88 | MDM4 (0.48) | MDM4TP53KMT2ACASP3MDM2 | |
| SCHEMBL18421130 | 0.88 | MDM4 (0.48) | MDM4TP53KMT2ACASP3MDM2 | |
| SCHEMBL1261331 | 0.88 | MDM4 (0.48) | MDM4TP53KMT2ACASP3MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127039-B2 | Sulfur-containing amino acid derivative | AJINOMOTO CO., INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071863-A1 | Sulfur-Containing Amino Acid Derivative | SLC7A5, CTH, CBS | MDM4 1996/4885TP53 3873/4885SLC17A5 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.